Total Payments
$1,394
2024 Payments
$280.40
Companies
14
Transactions
37
Medicare Patients
16,307
Medicare Billing
$12.1M
Payment Breakdown by Category
Food & Beverage$1,381 (99.1%)
Education$12.69 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,381 | 36 | 99.1% |
| Education | $12.69 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $305.39 | 6 | $0 (2024) |
| Genentech USA, Inc. | $227.03 | 8 | $0 (2024) |
| Allergan Inc. | $206.82 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $141.21 | 4 | $0 (2019) |
| Alimera Sciences, Inc. | $127.72 | 2 | $0 (2019) |
| Biogen, Inc. | $122.33 | 2 | $0 (2024) |
| Genentech, Inc. | $64.69 | 3 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $63.21 | 3 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $36.81 | 2 | $0 (2023) |
| Apellis Pharmaceuticals, Inc. | $24.14 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $280.40 | 10 | Regeneron Healthcare Solutions, Inc. ($117.72) |
| 2023 | $312.37 | 10 | Biogen, Inc. ($95.81) |
| 2022 | $27.40 | 1 | Genentech, Inc. ($27.40) |
| 2021 | $16.62 | 1 | Xeris Pharmaceuticals, Inc. ($16.62) |
| 2020 | $22.29 | 1 | Genentech, Inc. ($22.29) |
| 2019 | $278.02 | 7 | Alimera Sciences, Inc. ($127.72) |
| 2018 | $341.85 | 6 | Allergan Inc. ($206.82) |
| 2017 | $115.14 | 1 | Regeneron Healthcare Solutions, Inc. ($115.14) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: UROLOGY | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: EYE CARE | ||||||
| 06/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $62.07 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/09/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Ophthalmology | ||||||
| 03/21/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Ophthalmology | ||||||
| 02/27/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/13/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Education | In-kind items and services | $12.69 | General |
| Category: Ophthalmology | ||||||
| 10/20/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Urology | ||||||
| 08/16/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/25/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Urology | ||||||
| 06/30/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/17/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $37.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/10/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/20/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Ophthalmology | ||||||
| 03/09/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $95.81 | General |
| 03/03/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $35.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/15/2022 | Genentech, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/09/2021 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: DIABETES | ||||||
| 03/12/2020 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: None | ||||||
| 10/23/2019 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: OCULAR | ||||||
| 10/10/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,704 | 33,556 | $6.6M | $3.2M |
| 2022 | 20 | 4,014 | 14,712 | $6.5M | $3.2M |
| 2021 | 23 | 4,807 | 12,965 | $6.9M | $3.6M |
| 2020 | 23 | 3,782 | 8,856 | $4.1M | $2.1M |
Total Patients
16,307
Total Services
70,089
Medicare Billing
$12.1M
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 426 | 2,546 | $3.2M | $1.7M | 54.7% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 160 | 24,480 | $1.4M | $710,699 | 50.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 78 | 1,196 | $598,000 | $214,433 | 35.9% |
| 67028 | Injection of drug into eye | Office | 2023 | 816 | 1,909 | $614,250 | $171,464 | 27.9% |
| J3590 | Unclassified biologics | Office | 2023 | 29 | 40 | $165,396 | $89,029 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 580 | 871 | $155,898 | $73,417 | 47.1% |
| 92134 | Imaging of retina | Office | 2023 | 869 | 1,474 | $103,040 | $38,962 | 37.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 203 | 429 | $124,990 | $27,200 | 21.8% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 23 | 24 | $54,720 | $20,848 | 38.1% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 22 | 24 | $54,480 | $20,249 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 284 | 342 | $42,386 | $17,265 | 40.7% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 14 | 14 | $33,180 | $11,696 | 35.3% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 12 | 12 | $31,800 | $11,220 | 35.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 81 | 87 | $17,325 | $7,189 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $11,745 | $5,074 | 43.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 48 | 49 | $6,957 | $3,249 | 46.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 12 | 12 | $2,808 | $722.40 | 25.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 452 | 3,076 | $3.8M | $2.2M | 57.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 119 | 1,602 | $805,500 | $353,636 | 43.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 777 | 1,975 | $628,750 | $181,006 | 28.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 38 | 3,480 | $198,673 | $103,848 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 600 | 1,033 | $171,478 | $91,151 | 53.2% |
| 92134 | Imaging of retina | Office | 2022 | 1,016 | 1,849 | $129,430 | $50,425 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 533 | 777 | $87,801 | $44,188 | 50.3% |
| J3490 | Unclassified drugs | Office | 2022 | 16 | 21 | $114,975 | $37,156 | 32.3% |
About Dr. Ashok Reddy, M.D
Dr. Ashok Reddy, M.D is a Ophthalmology healthcare provider based in Albuquerque, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225028228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashok Reddy, M.D has received a total of $1,394 in payments from pharmaceutical and medical device companies, with $280.40 received in 2024. These payments were reported across 37 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,381).
As a Medicare-enrolled provider, Reddy has provided services to 16,307 Medicare beneficiaries, totaling 70,089 services with total Medicare billing of $12.1M. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Albuquerque, NM
- Active Since 10/21/2005
- Last Updated 04/25/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1225028228
Products in Payments
- OZURDEX (Drug) $227.03
- EYLEA (Biological) $165.25
- Vabysmo (Drug) $135.82
- Iluvien (Drug) $127.72
- EYLEA AFLIBERCEPT INJECTION (Biological) $115.14
- Lucentis (Biological) $106.21
- GEMTESA (Drug) $63.21
- XIPERE (Drug) $36.81
- SUSVIMO (Drug) $27.40
- BYOOVIZ (Biological) $26.52
- EYLEA HD (Biological) $25.00
- BROLUCIZUMAB (Drug) $24.67
- Syfovre (Drug) $24.14
- Non-Covered Product (Drug) $22.29
- AcrySof (Device) $19.74
- LUXTURNA (Biological) $18.17
- GVOKE PFS (Drug) $16.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Albuquerque
John Pitcher, M.d, M.D
Ophthalmology — Payments: $351,399
Ophthalmology $351,399
Robert Melendez, M.d, M.D
Ophthalmology — Payments: $260,758
Ophthalmology $260,758
Dr. Christopher Roybal, M.d, M.D
Ophthalmology — Payments: $53,047
Ophthalmology $53,047
Stephen Coleman, Md, MD
Ophthalmology — Payments: $15,456
Ophthalmology $15,456
Rachel Davis
Ophthalmology — Payments: $13,286
Ophthalmology $13,286
Arup Das, Md, MD
Ophthalmology — Payments: $11,111
Ophthalmology $11,111